Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 187articles · 30d
- 7+ hour agolatest article
- Aug 14, 2026earliest in window
- 89%with images
- 245avg words
- Medical 138
- Health & Wellness 101
- Economy, Business & Finance 80
- Health 74
- Business & Industrial 65
- Finance & Business 32
- Science & Technology 21
- News 14
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
India administers 80 lakh HPV vaccine doses
9+ hour, 3+ min ago (299+ words) Gujarat, Uttar Pradesh, Madhya Pradesh, and Mizoram have achieved 100 per cent coverage of their respective identified target populations India has crossed a significant milestone in its efforts to prevent cervical cancer and has administered more than 80 lakh doses of Human…...
FUJIFILM installs first DLR-Enabled Echelon Smart MRI at Jansons Health
8+ hour, 10+ min ago (343+ words) FUJIFILM India has installed and commissioned its Echelon Smart MRI at JANSONS HEALTH in Erode, Tamil Nadu, expanding access to advanced MRI diagnostics beyond major urban centres. The installation marks a significant milestone for FUJIFILM India as the company’s first…...
J&J receives CE Mark for ACUVUE OASYS MAX 2-Week reusable contact lens
8+ hour, 57+ min ago (345+ words) Johnson & Johnson has received the CE Mark for its ACUVUE OASYS MAX 2-Week reusable contact lens, featuring the company’s MAX technologies, paving the way for its introduction in select European markets later this year. The lens is expected to launch…...
AI moves from promise to practical impact in public health: Dr. Vikram Niranjan, University of Limerick
8+ hour, 57+ min ago (659+ words) For India, the opportunity is to combine technological capability with public-health experience, clinical expertise and community trust Dr. Vikram Niranjan, Associate Professor of Public Health, School of Medicine, University of Limerick, Ireland. Artificial intelligence is increasingly moving from discussion to…...
Meril launches HALO Stem, Latitud Revision Cup for Indian hip replacement needs
7+ hour, 55+ min ago (361+ words) HALO (Hybrid Asian Low Offset) Stem. Meril Life Sciences has launched the HALO (Hybrid Asian Low Offset) Stem and Latitud Revision Acetabular Cup System, expanding its total hip arthroplasty portfolio with implants designed specifically to address anatomical and surgical considerations…...
HBA India Summit puts spotlight on India’s rising role in global healthcare leadership
8+ hour, 4+ min ago (379+ words) The question confronting healthcare leaders is no longer simply how to manage change, but how to influence it These themes formed the backdrop to the Healthcare Businesswomen’s Association (HBA) India’s third India Leadership Summit (ILS) 2026, held in Hyderabad on September…...
Novo Nordisk trial finds semaglutide cuts obesity in children aged 6–11
3+ day, 21+ hour ago (63+ words) The findings are particularly significant because the trial population had a high burden of severe obesity Novo Nordisk trial finds semaglutide cuts obesity in children aged 6–11 MED-EL launches SONNET 3 cochlear implant audio processor in India Apollo Hospitals Navi Mumbai launches…...
SMT enters Canadian market with Health Canada licence for Supraflex Cruz coronary stent
3+ day, 14+ hour ago (430+ words) Sahajanand Medical Technologies Limited (SMT) has received a Class IV medical device licence from Health Canada’s Medical Devices Directorate for its Supraflex Cruz sirolimus-eluting coronary stent system, marking the company’s entry into the Canadian market. The family licence covers the…...
Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate
4+ day, 54+ min ago (88+ words) Indian Pharma Post Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device assessment for ACT-101, supporting Aceso’s clinical development roadmap Chasing Consistency:…...
Neurizon appoints Dr. Chris Bremer as CEO
4+ day, 1+ min ago (277+ words) Neurizon Therapeutics has appointed Dr. Chris Bremer as Chief Executive Officer, effective October 1, 2026 while the Australian biotechnology company advances its lead ALS drug candidate NUZ-001. Dr. Bremer will initially serve as CEO and will not join the board of Neurizon…...